• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Zhongchao Inc.

    7/7/23 4:28:17 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate
    Get the next $ZCMD alert in real time by email
    6-K 1 ea181497-6k_zhongchao.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of July 2023

     

    ZHONGCHAO INC.

    (Exact name of registrant as specified in its charter)

     

    Nanxi Creative Center, Suite 218

    841 Yan’an Middle Road

    Jing’An District, Shanghai, China 200040

    Tel: 021-32205987 (Address of Principal Executive Office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F  ☒      Form 40-F  ☐

     

     

     

     

     

     

    Zhongchao Inc., a Cayman Islands exempt company (the “Company”) held its 2023 annual general meeting (the “Meeting”) of shareholders at 9:00 a.m. Eastern Time, July 5, 2023, at Nanxi Creative Center, Suite 218, 841 Yan’an Middle Road, Jing’An District, Shanghai, People’s Republic of China. Each Class A Ordinary Share is entitled to one vote, and each Class B Ordinary Share is entitled to fifteen votes. Holders of a total of 20,223,960ordinary shares (consisting of 14,726,245 Class A Ordinary Shares and 5,497,715 Class B Ordinary Shares), out of a total of 24,679,070shares (consisting of 19,181,355 Class A Ordinary Shares and 5,497,715 Class B Ordinary Shares) issued and outstanding and entitled to vote at the Meeting have voted. Therefore, a quorum of more than a third of the shares outstanding and entitled to vote at the annual general meeting of shareholders as of the record date of May 11, 2023 was reached. The final voting results for each matter submitted to a vote of shareholders at the meeting are as follows:

     

    1. Re-election of Directors

     

    The following individuals were re-elected as directors to serve on the Board of Directors of the Company, to hold office, 1) for Class I directors, until the second annual general meeting of shareholders following his/her election, 2) for Class II directors, until the annual general meeting of shareholders in 2024 (the third annual general meeting of shareholders following the initial meeting in 2021), and until his/her respective successor is elected and duly qualified.

     

    Director’s Name   For   Against   Abstain
    Weiguang Yang (Class II)   85,106,205   31,779   8,574
                 
    Pei Xu (Class II)   85,106,205   31,778   8,575
                 
    John C. General (Class I)   85,089,884   47,900   8,774
                 
    Kevin Dean Vassily (Class I)   85,091,634   46,349   8,575
                 
    Dan Li (Class I)   85,091,487   46,497   8,574

     

    2. Ratification and Approval of the Appointment of the Independent Registered Public Accounting Firm

     

    It was approved to ratify the appointment of Prager Metis CPAs, LLC as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2022, and that the appointment of Prager Metis CPAs, LLC as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2023. 

     

    For   Against   Abstain
    97,091,131   92,264   8,575

     

    3. Amendment of Amended and Restated Articles of Association

     

    It was approved to amend the Company’s amended and restated articles of association as currently in effect (the “Existing Articles”) by deleting Article 3 in its entirety and replacing it with the new Article 3, as set forth below.

     

    Current Article 3   New Article 3

    3 Alteration of Articles

    Subject to any other provision of these Articles, the Company may from time to time alter or add to these Articles by passing a Special Resolution so long as such alteration does not disparately impact the members’ voting rights.

     

    3 Alteration of Articles

    Subject to any other provision of these Articles, including but not limited to Article 9 (Variation of Rights of Shares), the Company may from time to time alter or add to these Articles by passing a Special Resolution.

     

    For   Against   Abstain
    85,088,956   47,810   9,792

     

    4. Varying the Rights of Each Class of Shares Currently Issued by the Company

     

    It was approved to vary the rights of each class of shares currently issued by the Company in such manner and to such extent such that all the Company’s Class B ordinary shares are designated as shares with the rights and privileges and subject to the limitations provided for  in the Company’s second amended and restated articles of association (the “Amended Articles”).

     

    For   Against   Abstain
    Class A Ordinary Shares
    2,623,351   47,808   9,674

     

    5. Adoption of the Second Amended and Restated Articles of Association

     

    It was approved to adopt the Amended Articles, a copy of which is attached as Exhibit 3.1, as the Company’s articles of association in substitution for and to the exclusion of the Company’s Existing Articles. 

     

    For   Against   Abstain
    85,089,076   48,808   8,674

     

    1

     

     

    Exhibits

     

    Exhibit No.   Description
    3.1   Amended and Restated Articles of Association adopted on July 5, 2023

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Zhongchao Inc.
       
    Date: July 7, 2023 By: /s/ Weiguang Yang
       

    Weiguang Yang
    Chief Executive Officer

     

     

    3

     

     

    Get the next $ZCMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZCMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZCMD
    SEC Filings

    View All

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    2/10/26 4:00:40 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    1/27/26 5:15:28 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    1/20/26 5:20:41 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    $ZCMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

    SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE) and reduced their financial challenges associated with long-term treatment. SLE is a chronic inflammatory autoimmune disease that affects multipl

    3/12/24 8:30:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    Zhongchao Inc. Announces 1-for-10 Share Consolidation

    SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that an extraordinary general meeting of shareholders held on Tuesday, February 20, 2024, approved the proposed 1-for-10 share consolidation of the Company's ordinary shares of US$0.0001 par value each (the "Share Consolidation"). Beginning with the opening of trading on February 29, 2024, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD", but under a new CUSIP num

    2/27/24 8:00:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

    SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its service agreement (the "Agreement") with Beijing Public Health Foundation ("BPHF"), a non-profit organization dedicated to enhancing Chinese citizens' health through public welfare initiatives and aid programs. Pursuant to the Agreement, Zhongxin and BPHF extended its par

    12/11/23 8:00:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    $ZCMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by ZHONGCHAO INC. (Amendment)

    SC 13D/A - Zhongchao Inc. (0001785566) (Subject)

    5/21/21 5:10:06 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate